Podcast appearances and mentions of Dan Ackerman

Dr. Dan Ackerman and Dr. Reza Bavarsad Shahripour discuss the diagnostic performance of 4 major modalities: TCD, TTE, TEE, and cardiac CT in patients with embolic stroke of undetermined source.  Sho citation:  Read the related article in Neurology® Clinical Practice.     

Dr. Dan Ackerman talks with Dr. Reza Bavarsad Shahripour about the diagnostic performance of 4 major modalities: TCD, TTE, TEE, and cardiac CT in patients with embolic stroke of undetermined source.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

In part two of this series, Dr. Andy Southerland and Dr. Dan Ackerman discuss a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care.  Show transcript:  Dr. Andy Southerland: Hello, everyone. This is Andy Southerland from the University of Virginia. And for today's Neurology Minute, I'm speaking with my friend and colleague, Dan Ackerman, Chief of Neurology and Director of Stroke at St. Luke's University Health System. We've been speaking in the main neurology podcast on tips for updated clinical practice related to the 2026 American Heart Association guidelines for the early management of patients with acute ischemic stroke. I'm going to hit Dan with a few rapid fire concepts that were touched on the guidelines that I think are new or provide some new insights, new based on the data and to how we treat patients. So Dan, you ready for it? Rapid fire, acute stroke treatment decision making? Dr. Dan Ackerman: Absolutely. Hit me. Dr. Andy Southerland: All right, Dan. I'm a resident going to my first stroke alert on July one this year and I've got a patient coming in, they're having disabling stroke symptoms and they're, in every other way, eligible to receive thrombolysis, but they have a history of paroxysmal atrial fibrillation. They are on apixaban and they took a dose of that apixaban. They forgot to take one yesterday, but they took one the day before, had the evening before. And so 36 hours ago, they took a dose of their apixaban. So based on previous dogma, I think prior guidelines might've said if it's within that 48 hour window, that's a relative contraindication of thrombolysis. What, say, you based on the new guidelines and then how do they inform us about making that decision? Dr. Dan Ackerman: I would actually say the new guidelines are a little bit more aligned with what you just said. You mentioned it as a relative contraindication to thrombolysis. I think before these guidelines came out, a lot of people would've said, "No, that is a strict contraindication to thrombolysis." And a lot of folks would run a stroke code or a stroke lid a little slower knowing that, hey, this person is on, whether it's apixaban, rivaroxaban, edoxaban, dabigatran, et cetera, any of these direct oral anticoagulants and say, "Well, no, we know that person's not a candidate for thrombolytics." Well, no, the newer guidelines would suggest that that is a relative contraindication, not a strict contraindication. And when we look back at studies on this, it has not been suggested that there is a big contribution in terms of exactly how long ago that last dose was. Was it two hours ago, 12 hours ago, 20 hours ago? And there has not been shown to be a clear benefit of testing for factor Xa activity levels, bleeding time and the like. So the guidelines do suggest that, hey, we need more data on this. It's not to, say, that this is 100% perfectly fine. Remember, that's a relative contraindication, so it's still a risk benefit discussion, but studies have not shown an increased risk for hemorrhagic complications in patients who have had recent DOAC exposure who receive IV thrombolysis otherwise according to the guidelines. So I would tend to offer it in that situation and make sure that we document what drugs someone's on, how long ago was their last dose, all of this kind of information in addition to what we might normally otherwise get down. Dr. Andy Southerland: Does that change, Dan, if they took the DOAC in the last 24 hours or even 12 hours? They took it last night, and they're presenting in the morning with their stroke-like symptoms? Dr. Dan Ackerman: The guideline just suggests less than 48 hours, and the data, to my knowledge, doesn't really delineate, at this point, any particular timeframe where we would say, no, there's a cutoff there at two hours or eight hours or 12 hours. So at this point, I would not use that as a way to decide not to offer thrombolysis based on that timeframe. Dr. Andy Southerland: Fair enough. I think that's very reasonable. And I think, again, it's always a good conversation to have either with your attending, if you're that resident on July 1, but particularly with the patient and their family on the risk-benefit of what we know based on the data. Well, that's all the time we have for this Neurology Minute. We hope this discussion will continue to help everyone out there in the hyperacute management of patients with acute ischemic stroke, making those difficult treatment decisions. Good luck.  

In part two of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care. Disclosures can be found at Neurology.org.

In part one of this series, Dr. Andy Southerland and Dr. Dan Ackerman discuss what stands out in the latest thrombolysis guidelines, how these decisions are applied in stroke center practice, and how to educate residents and fellows on incorporating new evidence into treatment choices. Show transcript: Dr. Andy Southerland: Hi. This is Andy Southerland from the University of Virginia, and for today's Neurology Minute, I'm speaking with my friend and colleague, Dan Ackerman, Chief of Neurology and Director of Stroke at St. Luke's University Health System. I've been speaking with Dan on the main neurology podcast regarding updates to acute stroke treatment related to the 2026 American Heart Association guidelines that came out in late January of this year on the early management of patients with acute ischemic stroke. For our episode today, we might focus our discussion around thrombolytic therapy thrombolysis, which is at the core of what we do as acute stroke neurologists when it comes to treatment decision-making. So maybe as a first prompt, Dan, when you look at these guidelines, what stands out to you as you're thinking about how you practice, how you all are practicing at your stroke center, and then specifically how we educate our residents, our fellows on what they need to know, particularly the newness of it when it comes to making thrombolysis treatment decisions? Dr. Dan Ackerman: With all the discussions we've had in the past, there have been a lot of specifics about certain studies and how they might affect practice, but this guideline really opened up a lot and gave us an opportunity to do things in a way that makes really good clinical sense and really brings a lot of practices that have now become common at some centers into the fore so that we can get that information out to everyone and make sure everyone has that same really high level of stroke care everywhere they go. I think the first thing that stands out to me is what did not change. And want to reinforce that, particularly for people who are just getting into this, stroke alert is a screening tool, not a severity score. It's not like an MI alert where you do an EKG and you see the tombstone wave and you say, "Oh, there's an MI and we're taking them to treatment." This is a screening tool, so it is meant to be highly sensitive at the cost of being specific. At our shop for a long time now, we have initiated stroke alert for anyone who presents either within 24 hours of acute onset of neurologic symptoms or has an unknown onset of acute neurologic symptoms and they are still symptomatic to some degree at the time of their presentation, and that's it. We don't make any other statements about how severe something is or what kinds of symptoms someone necessarily has to have. We purposely keep it as broad as possible, again, because we're trying to screen. And the other thing that has not changed, time is still brain. So with all of these different nuances on how we can treat patients and who might be candidates for intervention, it is still a matter of understanding these guidelines, applying our best evidence, but doing it as quickly as possible to make sure that we are rescuing as much of that ischemic penumbra as we possibly can. Now, aside from that, in terms of what stands out that is different, I think one of the early things for me are the recommendations for extended time window for IV thrombolysis. So when you look at the original studies, we understand that when you get out beyond four and a half hours, if you just take all-comers, the risk is going to start to outweigh the benefit. But that doesn't mean there's zero benefit or that no one would receive benefit, but it's a question of, well, how do we cherry-pick those patients who may still receive benefit? And there are a few real specifics in the guideline that help us figure that out. One is for patients who have an unknown time of onset, but they're within four and a half hours of symptom discovery. And for those patients, they would suggest that doing a stat MRI and comparing a DWI lesion with the corresponding area flare to determine if you see DWI hyper-intensity and the flare image is nice and normal, that would suggest that stroke is young enough that it may still be appropriate to treat that patient. But we would also say for folks who have salvageable ischemic penumbra, so again, brain at risk that is not core yet, who either awoke with stroke symptoms within nine hours from the midpoint of sleep or, and this is the kicker, are within four and a half to nine hours from last known well. So in other words, they may have been symptomatic already for more than four and a half hours. If those patients have an appropriate ischemic penumbra, it may be reasonable to treat them with IV thrombolysis to improve functional outcomes. Dr. Andy Southerland: Well, that's all for this Neurology Minute. We hope this vibrant conversation will help all those who are out looking to make the best treatment decisions for their patients, both based on established evidence and most recent evidence in our new guidelines.  

In part one of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about the latest guidelines for managing acute ischemic stroke, emphasizing thrombolytic therapy, imaging techniques, and decision-making regarding treatment in extended time windows. Disclosures can be found at Neurology.org. 

Listen to a challenging message from Ps Dan Ackerman as we enter Week 6 of the ‘Tear Down the Idols' series.To find out more about LIFE, visit us at ⁠⁠⁠⁠⁠lifenz.org

The May 2026 Recall highlights four in‑depth conversations focused on the clinical approach to monocular vision loss. The episode opens with Dr. Dan Ackerman leading a two-part series with Drs. Valérie Biousse and Nancy J. Newman on the challenges and opportunities in diagnosing CRAO and BRAO. The episode continues with a second, two‑part series in which Dr. Justin Abbatemarco speaks with Drs. Valérie Biousse and Nancy J. Newman about updates in non‑arteritic ischemic optic neuropathy. Podcast links: Challenges and Opportunities in Diagnosing CRAO/BRAO - Part 1 Challenges and Opportunities in Diagnosing CRAO/BRAO - Part 2 Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 1  Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 2  Related article: Eye Stroke Protocol in the Emergency Department  Disclosures can be found at Neurology.org. 

[Overview] Explore Meta's new smart glasses, Google's offline dictation breakthrough, and the surprising ways AI is shaping our daily lives—plus, why cows now wear solar-powered smart collars. Steven Scott and Shaun Preece dive into the latest tech stories with their trademark insight and humour. From Meta's new Blayzer and Scriber smart glasses designed for all-day wear to Google's AI Edge Eloquent dictation app on iOS, discover how wearable and voice tech is evolving. They discuss Amazon ending support for pre-2012 Kindle devices and the worrying trend of tech companies rendering hardware obsolete, raising questions about e-waste and consumer rights. Dan Ackerman of Microcenter News shares survey insights on how Americans trust—and use—AI, from medical advice to problem solving. The episode rounds off with Waymo's self-driving cars identifying potholes for cities and a fascinating look at Halter's solar-powered smart collars for managing cattle with virtual fences. Relevant Links Microcenter News: https://www.microcenternews.com ----Follow on:YouTube: https://www.doubletaponair.com/youtubeX (formerly Twitter): https://www.doubletaponair.com/xInstagram: https://www.doubletaponair.com/instagramTikTok: https://www.doubletaponair.com/tiktokThreads: https://www.doubletaponair.com/threadsFacebook: https://www.doubletaponair.com/facebookLinkedIn: https://www.doubletaponair.com/linkedin Subscribe to the Podcast:Apple: https://www.doubletaponair.com/appleSpotify: https://www.doubletaponair.com/spotifyRSS: https://www.doubletaponair.com/podcastiHeadRadio: https://www.doubletaponair.com/iheart About Double TapHosted by the insightful duo, Steven Scott and Shaun Preece, Double Tap is a treasure trove of information for anyone who's blind or partially sighted and has a passion for tech. Steven and Shaun not only demystify tech, but they also regularly feature interviews and welcome guests from the community, fostering an interactive and engaging environment. Tune in every day of the week, and you'll discover how technology can seamlessly integrate into your life, enhancing daily tasks and experiences, even if your sight is limited."Double Tap" is a registered trademark of Double Tap Productions Inc. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Caterpillar, which manufactures heavy duty equipment like asphalt pavers, diesel engine locomotives, and industrial gas turbines, has been around for 101 years. And now, the company seems to be one of the big winners of the AI infrastructure build out.Big tech companies are working as fast as possible to get their data centers up to power artificial intelligence. Some are building their own natural gas plants to provide electricity for those data centers. Enter Caterpillar, maker of electric generators. Marketplace's Dan Ackerman has been reporting on this.

Caterpillar, which manufactures heavy duty equipment like asphalt pavers, diesel engine locomotives, and industrial gas turbines, has been around for 101 years. And now, the company seems to be one of the big winners of the AI infrastructure build out.Big tech companies are working as fast as possible to get their data centers up to power artificial intelligence. Some are building their own natural gas plants to provide electricity for those data centers. Enter Caterpillar, maker of electric generators. Marketplace's Dan Ackerman has been reporting on this.

In the second part of this two-part series, Dr. Dan Ackerman talks with Drs. Valérie Biousse and Nancy J. Newman about recent clinical trials, the need for collaboration between stroke neurologists and eye care providers, and the role of technology in improving patient outcomes.  Read the article referenced in this interview in the Journal of Stroke & Cerebrovascular Diseases.  Disclosures can be found at Neurology.org.  

Drs. Dan Ackerman, Valérie Biousse, and Nancy J. Newman discuss the clinical presentations, diagnostic challenges, and the importance of accurate diagnosis in managing CRAO and BRAO.  Show citation: Bénard-Séguin É, Nahab F, Pendley AM, et al. Eye stroke protocol in in the emergency department. J Stroke Cerebrovasc Dis. 2024;33(9):107895. doi:10.1016/j.jstrokecerebrovasdis.2024.107895 

In part one of this two-part series, Dr. Dan Ackerman talks with Drs. Valérie Biousse and Nancy J. Newman about the clinical presentations, diagnostic challenges, and the importance of accurate diagnosis in managing CRAO and BRAO.  Read the article referenced in this interview in the Journal of Stroke & Cerebrovascular Diseases.  Disclosures can be found at Neurology.org.  

Rare-earth elements help power our everyday electrical devices, and that's because most batteries are made with minerals like lithium, nickel, cobalt and graphite. As of now, China has the largest reserve of these minerals. But some mining companies are eyeing the deep sea's floor, says Marketplace contributor Dan Ackerman, because such rare earths form organically way down there. Plus, the ethical concerns that come with this deep-sea mining.Here's everything we talked about today:“Companies are betting on deep sea mining for critical minerals” from Marketplace Tech“New policies may part the waters for ocean mining” from Marketplace Morning Report“In the depths of the ocean, a new contest between the US and China emerges” from The Guardian“Trump's New Executive Order Promotes Deep Sea Mining in US and International Waters While Bypassing International Law” from Inside Climate News

Rare-earth elements help power our everyday electrical devices, and that's because most batteries are made with minerals like lithium, nickel, cobalt and graphite. As of now, China has the largest reserve of these minerals. But some mining companies are eyeing the deep sea's floor, says Marketplace contributor Dan Ackerman, because such rare earths form organically way down there. Plus, the ethical concerns that come with this deep-sea mining.Here's everything we talked about today:“Companies are betting on deep sea mining for critical minerals” from Marketplace Tech“New policies may part the waters for ocean mining” from Marketplace Morning Report“In the depths of the ocean, a new contest between the US and China emerges” from The Guardian“Trump's New Executive Order Promotes Deep Sea Mining in US and International Waters While Bypassing International Law” from Inside Climate News

Dr. Dan Ackerman and Dr. Isabel Hostettler discuss the diagnosis, risk factors, and prognosis of RCVS, highlighting the need to recognize symptoms and distinguish it from other causes of subarachnoid hemorrhage.  Show reference:  Hostettler IC, Ponciano A, Wilson D, et al. Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis. Neurology. 2025;105(5):e213984. doi:10.1212/WNL.0000000000213984 

Dr. Dan Ackerman talks with Dr. Isabel Hostettler about the diagnosis, risk factors, and prognosis of RCVS, highlighting the need to recognize symptoms and distinguish it from other causes of subarachnoid hemorrhage. Read the related article in Neurology®.  Disclosures can be found at Neurology.org.  

#Windows10 #Windows11 #PCUpgrade #YourTechReport #MicroCenter Windows 10 support ends October 14. Dan Ackerman (Editor-in-Chief, Micro Center News) joins Your Tech Report to explain what end of updates means, why Windows 11 adoption lagged, hardware requirements, the ESU “snooze” option, and why desktops and DIY builds are surging again. Windows 10 has been the comfortable default for a decade, but support is ending. Dan Ackerman outlines what changes after October 14: no ongoing feature updates and only limited coverage for users who enroll in Microsoft's extended service option. He explains why people stuck with Windows 10—stability, habit, and early Windows 11 friction—and how hardware requirements like TPM factored in. For most systems from the last five to six years, a Windows 11 upgrade should be straightforward. Older machines may struggle, especially laptops, whereas desktops can be refreshed with parts. Dan notes a shift toward desktops for customization, gaming, and local AI—where big GPUs, abundant RAM, and ample storage shine. He also touches on the ESU route as a temporary bridge for consumers and businesses who need more time. Looking ahead, Dan is excited about next-gen handheld gaming PCs (including a Lenovo Legion Go 2 with OLED and Ryzen “Xtreme Z2”) and broader holiday PC interest. Listeners can find more of his coverage and tools at Micro Center's sites. Subscribe for more practical tech explainers and interviews. Explore more from Micro Center: microcenter.com and microcenter.news Micro Center: https://www.microcenter.com Micro Center News: https://microcenter.news Expanded SummaryCall to ActionRelevant Links Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation.  show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00439-8/fulltext  

Dr. Dan Ackerman talks with Dr. Urs Fischer about the optimal timing of anticoagulation after ischemic stroke in patients with atrial fibrillation.  Read the related article in The Lancet.  Disclosures can be found at Neurology.org.   

Dr. Dan Ackerman and Dr. James Ernest Siegler discuss the complexities of treating ESUS and emphasize the importance of personalized treatment approaches based on individual patient factors.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213876 

Dr. Dan Ackerman talks with Dr. James Ernest Siegler about the complexities of treating ESUS and emphasizes the importance of personalized treatment approaches based on individual patient factors.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Dr. Dan Ackerman and Drs. Luuk Dekker and Jasper D. Daems discuss the analysis of various aLVO stroke detection scales to determine which one is the most useful for prehospital triage. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213570 

Dr. Dan Ackerman talks with Drs. Luuk Dekker and Jasper D. Daems about analyzing various anterior-circulation large-vessel occlusion (aLVO) stroke detection scales to determine which one is the most useful for prehospital triage. Read the related article in Neurology®.  Disclosures can be found at Neurology.org.   

In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.

In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic. 

Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.  Disclosures can be found at Neurology.org.   

Dr. Dan Ackerman and Dr. Phillip Ferdinand discuss the impact smoking has on stroke risk.  Show reference: https://www.neurology.org/doi/10.1212/WN9.0000000000000003 

Dr. Dan Ackerman talks with Dr. Phillip Ferdinand about the association between smoking and young cryptogenic ischemic stroke. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org.

In this episode of Your Tech Report, Marc Aflalo dives into all things CES 2024 with Dan Ackerman, Editor-in-Chief of Micro Center News. The duo shares insights, anecdotes, and expert opinions on the year's biggest tech trends. From the transformative role of AI in GPUs to groundbreaking handheld gaming devices and the resurgence of wearable tech, this conversation is packed with fresh perspectives. Dan even reveals his personal must-have gadget from the show! Highlights include Nvidia's game-changing AI advancements, Lenovo's new handheld gaming systems, Dell's simplified product naming strategy, and the practical perks of Meta's Ray-Ban smart glasses. The discussion also touches on the ethical implications of AI and its role as an essential tool for the future. Show Notes: 1. Key CES Trends • This year's focus on chips and hardware innovation. • The shift towards locally run AI models for privacy and performance. 2. Nvidia Announcements • RTX 50-series GPUs: AI-powered frame generation and upscaling. • Mid-range 5070 priced at $549, delivering performance comparable to high-end 4090. • AI workstations starting at $3,000. 3. Gaming Devices • Lenovo Legion Go: New models featuring Steam OS. • MSI Claw and Acer Blaze handhelds, including an 11-inch AMD-powered tablet with detachable controllers. • The versatility of gaming tablets running full Windows OS. 4. Streaming and Game Access • Nvidia GeForce Now expanding to devices like Steam Deck, MetaQuest, and Apple Vision Pro. 5. Dell's Rebranding • Simplified product tiers: Dell, Dell Pro, Dell Plus, Dell Max. • Comparing the new structure to Apple's straightforward naming strategy. 6. Wearable Tech • Meta's Ray-Ban smart glasses: A CES favorite for practical phone calls and audio use. • The rise of smart wearables with AI functionality beyond flashy marketing. 7. Ethics and AI • The ongoing debate about responsible AI use. • AI as a tool to enhance human work rather than replace it. 8. Best Gadget of CES • ASUS XG Mobile: Portable Nvidia 5090 external GPU for Thunderbolt laptops. Why Listen: Marc and Dan's engaging discussion provides a comprehensive overview of CES 2024's standout products and trends. Whether you're into gaming, AI, or wearable tech, this episode breaks down the year's biggest innovations with humor, insight, and practical takeaways. Don't miss the expert predictions for how these technologies will shape the future of tech! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of YourTechReport, Marc connects with Dan Ackerman, Editor in Chief of Micro Center News, to dive into their unique experiences of switching between Mac and Windows systems. Dan shares his insights on how Windows has evolved, particularly for gaming and creative tasks, and the pros and cons of each platform. They discuss the small yet powerful nuances that make each system unique—from Mac's spacebar preview to Windows' flexibility with gaming. Dan also reveals details about his recent AI cloning experiment, where he created a virtual version of himself that can respond in real-time for videos and even conduct interviews. With tools like ChatGPT, Eleven Labs, and HeyGen, Dan's exploration into AI demystifies the process of creating a realistic digital clone for under $50. They touch on the potential of AI avatars in customer service, video narration, and content creation, along with the ethical implications and future of AI in tech. With Black Friday around the corner and CES on the horizon, Marc and Dan also talk shop about the latest developments in PC gaming, the launch of new Intel and AMD chips, and Micro Center's expansion into Miami. Whether you're a tech enthusiast, curious about AI, or just looking for the next upgrade, this episode has something for everyone. Chapters: 1. 00:00 - Mac vs. Windows: A Tale of Two Systems 2. 02:15 - Transitioning Back to Windows: The Pros and Cons 3. 03:30 - Dan's AI Cloning Experiment: Cloning Yourself for $50 4. 05:00 - Tools for AI Cloning: ChatGPT, Eleven Labs, and HeyGen 5. 06:45 - Building Real-Time AI Conversations 6. 09:00 - The Future of AI in Customer Service & Content Creation 7. 11:00 - What's New in the PC World: Intel & AMD Chips 8. 12:15 - Micro Center's New Miami Store and Canada Expansion 9. 14:00 - Closing Thoughts & Upcoming Holiday Tech Buzz Learn more about your ad choices. Visit megaphone.fm/adchoices

Vice President Kamala Harris plans to unveil ideas designed to make life easier for small business owners. Her announcement comes as polling continues to give former President Donald Trump the advantage among voters when they're asked who can better handle the economy.The FBI's Internet Crime Complaint Center saw more than 880,000 complaints last year, a 10% increase from 2022. Dan Ackerman, editor-in-chief of Micro Center News, joins "CBS Mornings" to discuss the rise of these threats.To lose weight, millions of Americans have turned to prescription medications that treat diabetes like Wegovy, Ozempic and others. However, some say they can have serious side effects. CBS News senior investigative consumer correspondent Anna Werner spoke to a Pennsylvania woman who is warning others about rare complications she said she experienced from a weight loss drug that she says left her fighting for her life.With just two months to go until Election Day, we continue the "Three Meals" series, sitting down with voters over breakfast, lunch and dinner. This time, Caitlin Huey-Burns heads to Florida, a former battleground state that's shifted more conservative in recent years.After nearly two decades representing over 300 of the biggest names in sports, Molly Fletcher has transitioned into a successful keynote speaker and author. She joins "CBS Mornings" to talk about her new book, "Dynamic Drive: The Purpose-Fueled Formula for Sustainable Success."See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Dan Ackerman and Dr. Luciano A. Sposato discuss the topic of embolic stroke of undetermined sources and the controversies surrounding cardiac monitoring and anticoagulation. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209535 

In part two of this two-part series, Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the differences in treatment between American Stroke Centers and those in France. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398  

Dr. Dan Ackerman talks with Dr. Luciano A. Sposato about the topic of embolic stroke of undetermined source and the controversies surrounding cardiac monitoring and anticoagulation.  Read the related article in Neurology.  Disclosures can be found at Neurology.org.

Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the efficacy and safety of both thrombolytics in patients with large ischemic core.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398  

Dr. Dan Ackerman talks with Dr. Gaspard Gerschenfeld about the efficacy and safety of both thrombolytics in patients with large ischemic core. Read the related article in Neurology.  Disclosures can be found at Neurology.org.

Dr. Dan Ackerman and Dr. Andy Southerland discuss the impact of glucose control on the risk of symptomatic intracerebral hemorrhage following thrombolysis for acute ischemic stroke. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209323  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. 

Dr. Dan Ackerman talks with Dr. Andy Southerland about the impact of glucose control on the risk of symptomatic intracerebral hemorrhage following thrombolysis for acute ischemic stroke. Read the related article in Neurology.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.

Dr. Dan Ackerman and Dr. Silja Räty discuss the outcomes of patients with basilar artery occlusion treated with intravenous thrombolysis (IVT) only and compares IVT with endovascular thrombectomy.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209249 

Dr. Dan Ackerman talks with Dr. Silja Räty about the outcomes of patients with basilar artery occlusion treated with intravenous thrombolysis (IVT) only and compares IVT with endovascular thrombectomy. Read the related article in Neurology. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.

This week, Marc Aflalo and Mitchell Whitfield discuss various tech topics, including the reimagining of Windows, the new Microsoft Surface devices, the comparison between Windows and Mac computers, and their experiences with the new iPad. They also mention the future of gaming and the potential shift towards PC gaming. Dan Ackerman from Micro Center News joins the conversation to share his perspective on Microsoft's Build Conference. At the Microsoft event, the big point of differentiation was the integration of AI in an accessible and friendly way. Microsoft showcased AI features that are coming to Windows, making it part of the workflow and useful. The focus was on how AI can help users rather than just showcasing its capabilities. Microsoft's approach is to make AI applications frictionless and seamlessly integrated into their products. The event also highlighted the shift from Intel to Qualcomm chips in PCs, signaling a potential change in the PC world. Apple may be under pressure to match Microsoft's advancements in AI and software integration. Chapters 00:00 Introduction and Overview 04:07 The Reimagining of Windows and the Advancements in Hardware 09:49 Comparing Windows and Mac Computers 13:07 Experiences with the New iPad Models 23:01 Using the Belkin iPhone Mount with MagSafe for Apple TV 4K 25:52 Navigating Tech Events and Finding Familiar Faces 26:22 Differentiation at Microsoft Event 28:16 Frictionless AI Integration 30:40 Endless Possibilities for Gamers 32:48 Shift from Intel to Qualcomm 35:13 Matching AI Capabilities 36:30 Apple Under Pressure Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Dan Ackerman, editor-in-chief of Micro Center News, talks about the current state of tech journalism and the importance of providing reliable tech advice to consumers. He explains how Micro Center News combines traditional and online storefronts to offer expert guidance. The conversation also touches on the challenges of navigating social media and the intersection of technology with other areas. Dan expresses his enthusiasm for building desktops and the potential of AI running on local machines, highlighting companies like Nvidia and Intel as leaders in AI development. The episode wraps up with a discussion of Micro Center News' future plans. Takeaways Micro Center News aims to provide reliable tech advice and consumer news. The tech journalism space continues to grow, and there is room for more publications. Navigating social media can be challenging due to the influx of poor quality information. Exciting developments include desktop building, AI on local machines, and advancements in AI by companies like Nvidia and Intel. Chapters 00:00 Introduction and Micro Center News 01:26 The State of Tech Journalism 03:02 Blending Traditional and Online Storefronts 04:22 Expanding Topics on Micro Center News 05:11 Navigating the Blurry World of Social Media 07:17 The Intersection of Tech and Other Areas 08:20 Geeking Out on Desktop Building 09:26 Tinkering with Technology 10:05 Interactivity and Audience Participation 11:29 Exciting Technological Developments 12:08 The Power of AI on Local Machines 13:15 Companies Excelling in AI 14:39 Micro Center News' Future Plans Learn more about your ad choices. Visit megaphone.fm/adchoices

** Don't miss out on an extra $5 rebate for all commercial VSP Eye Exams extended through December 31, 2024. Earn up to an additional $15,000 in 2023 and up to $30,000 in 2024. Visit www.pecaaexamrebate.com now!**In this episode, my guest is Founder & CEO of focalCenter, Dr. Ron Krefman to discuss the power of leveraging demographic data in understanding who your patients are, how to market to them, and how to grow. To get PECAA member pricing on localEyes, visit localEyes and use Discount Code "PECAA". Key Takeaways:Data, specifically demographic data, are valuable in understanding who your patients are and what opportunities exist within your practice to grow.Most patient consumers are willing to drive 20-30 minutes for their eye and health care.Data are only as valuable as the insights they provide and the decisions they impact within the practice.Leveraging the focalCenter localEyes report provides insights like who your target market is, who you should direct your marketing towards, and the utilization of eye care services in your trade area, the amount they're wiling to spend on eyewear, and more.Make one change at a time. Test it, learn from it, and adjust based on what worked and what didn't.Data like this should be reviewed regularly for the insights they provide and should be updated every 2-3 years.What Ron is reading:The Tetris Effect by Dan Ackerman

The US Supreme Court declined a recent request from Epic regarding the company's ongoing legal battles with Apple. Disney is getting ready to hike subscription fees (again) on Disney+ and other streaming services. And some astronomers worry that slamming spacecraft into oncoming asteroids might not actually remove the risk of catastrophe.See omnystudio.com/listener for privacy information.

Dr. Dan Ackerman talks with Dr. Thanh Nguyen about whether dual antiplatelet therapy is noninferior to intravenous thrombolysis among patients with minor nondisabling acute ischemic stroke. Read the related article in JAMA. Visit NPUb.org/Podcast for associated article links. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Rich talked about his trip to Hawaii. You can see the highlights on his Instagram here.Rich mentioned the Nintendo Game and Watch as a good alternative to phones and tablets for kids on vacation. Also, if they want iPad, Apple Arcade games are great since they don't require an internet connection and there are no in-app purchases. You can usually find a deal for a few free months in the Target app or through Best Buy.Rich noticed a lot of restaurants in Hawaii are using the Toast handheld tablet to take orders and process payment at the table, which is good for efficiency and security. Some restaurants are also printing QR codes on the bill which you can scan with your phone and pay via Apple Pay and Google Pay, which is also great when you just want to finalize your bill and be on your way fast.Rich mentioned a few methods for finding things to do on your trip, including Yelp. He sorts by Most Reviewed to find the most popular places nearby but consider going to the second most popular place since the first might be slammed. On Google Maps, he likes to sort by top rated and narrow down by filters.Instagram has a hidden feature for finding cool things to do. To find it, type in the city you're visiting, then hit Search. Next hit Places, then tap the city name. Finally, hit the X and you can now see the most Instagrammed spots and sort by Restaurants, Cafes, Sights, Hotels, Parks and more.Shirl called in and asked about how to improve her router security. Rich recommended being aware of the links she's clicking on and watching out for phishing emails. If you really want hardware protection between you and the internet at large, look into a device like Firewalla.John Simmons of Hyundai joined Rich to talk about the Ioniq 6 EV.Eileen called in to ask if you can port landline numbers to a cellular service.Rich talked about Google dropping support for Dropcam and Nest Secure in 2024. Rich recommended going with a service like SimpliSafe or Ring.Rich mentioned that Disney+ with Ads is now available on Roku.Kevin called in to ask how to get data off of old cell phones that he wants to donate or recycle.Rich talked about the Western Digital MyCloud outage due to potential hacking… and explained how you might be able to use a feature called Local Access to enable local, direct access to files stored on the drive in the meantime.Max called in and asked about how to go completely streaming but wants someone to do it for them. Rich recommended looking up in Yelp for a local tech support person.Danny Mizrahi of Sunbird Messaging called in to explain how they're building an app that lets you iMessage on Android phones.Ron called in and asked about CRM software for his small legal business. Rich recommended looking at offerings from Salesforce, Zoho, HubSpot and more. Rich mentioned his “vs” trick for Google searches. If you know one company and want to see the competitors start typing COMPANY NAME vs into Google and see what autocomplete brings up.Best Buy is now offering gadget recycling boxes. Just order a small or medium box for $23 or $30, load it up with old gadgets, tablets, cords, keyboards and more and send it in. Rich also recommended Gizmogo.com to recycle old gadgets and Staples where you can bring items in for recycling.Doug called in to vent about his internet service constantly being down. Rich recommended checking service outage pages and services including Down for Everyone or Just Me and Down Detector.Rich talked about Walmart adding EV charging stations at locations nationwide by 2030.Dan Ackerman, author of Tetris Effect, joined to talk Tetris movie on Apple TV +!If you love Tetris, Dan recommended Lumines and Candy Crush.Rich ran down some tips from the Better Business Bureau about how to do some digital spring cleaning.Rich talked about how Google Flights now has a price protection guarantee. If the price of your booked flight goes lower, Google will pay you the difference. The catch is that the flight you book has to have the price protection badge.Ruth wrote in and asked about how to protect her credit card from being hacked. Rich recommended using Tap to Pay when possible, protecting her card number by using one time virtual card numbers from her bank or a third party service like Privacy.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dan Ackerman gets a first look at what comes in the retail packaging of the PSVR2.

Dan Ackerman from CNET has the MacBook Air M2 in hand and talks about his review of the device. Richard Lawler from The Verge discusses how Netflix is partnering with Microsoft and its ad platform to start an ad-supported streaming tier. Jason talks about how kids and teens are spending more time on TikTok over YouTube or Google's overall core products. And Mikah talks about the recently leaked Uber Files showcasing leaked messages and files that detail attempts to lobby various high-profile personnel. Hosts: Jason Howell and Mikah Sargent Guests: Dan Ackerman and Richard Lawler Download or subscribe to this show at https://twit.tv/shows/tech-news-weekly. Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit Sponsors: Secureworks.com drata.com/twit ClickUp.com use code TNW